相关临床试验
52
5 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
2010
进行中（未招募）
3
5.8%
已完成
34
65.4%
Enrolling By Invitation
1
1.9%
尚未招募
1
1.9%
招募中
7
13.5%
Unknown
6
11.5%
暂无批准数据
- A randomized placebo-controlled Finnish study found that aspirin therapy after desensitization does not provide significant relief for patients with chronic rhinosinusitis with nasal polyps who are hypersensitive to NSAIDs. - Only 25% of patients receiving aspirin could be classified as benefiting from therapy, while 18% had to discontinue treatment due to adverse effects including respiratory symptoms and bleeding tendency. - The findings challenge the current practice of long-term aspirin therapy for N-ERD patients and suggest clinicians should consider more effective biologic treatments despite their higher cost.
- A new study found that vitamin D supplementation, even at high doses, does not reduce the risk of developing type 2 diabetes in healthy older adults. - The research involved nearly 2,300 participants aged 60 or older who were given either a placebo or vitamin D3 supplements over five years. - No significant differences were observed in the rates of type 2 diabetes development among the placebo and vitamin D groups. - The findings suggest that increasing vitamin D intake does not alter the odds of diabetes or its risk factors for healthy, non-prediabetic individuals.
- Finnish researchers have developed an ML-powered tool called HASTEN that reduces virtual drug screening time from 6 months to under 10 days for 1.56 billion molecules. - The system successfully identified 90% of top-scoring drug candidates when screening just 1% of the compound library against bacterial and viral targets. - Orion Pharma and University of Eastern Finland researchers have made their datasets public to advance computational drug discovery research.
